PA8620501A1 - USEFUL COMPOUNDS IN THERAPY - Google Patents
USEFUL COMPOUNDS IN THERAPYInfo
- Publication number
- PA8620501A1 PA8620501A1 PA20048620501A PA8620501A PA8620501A1 PA 8620501 A1 PA8620501 A1 PA 8620501A1 PA 20048620501 A PA20048620501 A PA 20048620501A PA 8620501 A PA8620501 A PA 8620501A PA 8620501 A1 PA8620501 A1 PA 8620501A1
- Authority
- PA
- Panama
- Prior art keywords
- therapy
- useful compounds
- compounds
- useful
- dismenorrea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
UN COMPUESTO DE FORMULA (I) O DERIVADOS DEL MISMO ACEPTABLES FARMACEUTICAMENTE, EN EL QUE CADA UNO DE LOS RESTOS SON COMO SE DETALLAN EN LA DESCRIPCION. LOS COMPUESTOS SON UTILES PARA TRATAR UN TRASTORNO PARA EL CUAL ESTA INDICADO UN ANTAGONISTA DE VLA, EN PARTICULAR LA DISMENORREA.A COMPOSITE OF FORMULA (I) OR DERIVATIVES OF THE SAME PHARMACEUTICALLY ACCEPTABLE, IN WHICH EACH OF THE REMAINS ARE AS DETAILED IN THE DESCRIPTION. THE COMPOUNDS ARE USEFUL TO TREAT A DISORDER FOR WHICH A VTA ANTAGONIST IS INDICATED, IN PARTICULATE THE DISMENORREA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0329693A GB0329693D0 (en) | 2003-12-22 | 2003-12-22 | Compounds useful in therapy |
GB0408789A GB0408789D0 (en) | 2004-04-20 | 2004-04-20 | Triazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8620501A1 true PA8620501A1 (en) | 2005-08-04 |
Family
ID=34740750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20048620501A PA8620501A1 (en) | 2003-12-22 | 2004-12-22 | USEFUL COMPOUNDS IN THERAPY |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1701959A1 (en) |
JP (1) | JP4698604B2 (en) |
KR (1) | KR100854872B1 (en) |
AP (1) | AP2331A (en) |
AR (1) | AR047340A1 (en) |
AU (1) | AU2004309164B2 (en) |
BR (1) | BRPI0417267A (en) |
CA (1) | CA2551038C (en) |
CR (1) | CR8481A (en) |
DO (1) | DOP2004001062A (en) |
EA (1) | EA010132B1 (en) |
EC (1) | ECSP066647A (en) |
GE (1) | GEP20084571B (en) |
HK (1) | HK1095822A1 (en) |
IL (1) | IL176349A (en) |
IS (1) | IS8472A (en) |
MA (1) | MA28393B1 (en) |
NL (1) | NL1027833C2 (en) |
NO (1) | NO20063380L (en) |
OA (1) | OA13347A (en) |
PA (1) | PA8620501A1 (en) |
PE (1) | PE20051051A1 (en) |
TW (1) | TWI287541B (en) |
UY (1) | UY28693A1 (en) |
WO (1) | WO2005063754A1 (en) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI335816B (en) | 2004-05-26 | 2011-01-11 | Eisai R&D Man Co Ltd | Cinnamide compound |
US7592343B2 (en) | 2004-09-20 | 2009-09-22 | Xenon Pharmaceuticals Inc. | Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors |
CN101083992A (en) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
TW200624427A (en) | 2004-09-20 | 2006-07-16 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
TW200626592A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
AU2005286728A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
CA2580855A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
MX2007003321A (en) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents. |
EP1808432B1 (en) | 2004-10-26 | 2010-02-24 | Eisai R&D Management Co., Ltd. | Amorphous form of cinnamide compound |
AP2007004047A0 (en) | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
CA2618646A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
JP2009502859A (en) * | 2005-07-29 | 2009-01-29 | エフ.ホフマン−ラ ロシュ アーゲー | Indol-3-yl-carbonyl-piperidine and piperazine derivatives |
TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
WO2008013622A2 (en) | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
US9090604B2 (en) | 2006-07-27 | 2015-07-28 | E I Du Pont De Nemours And Company | Fungicidal azocyclic amides |
SA07280403B1 (en) | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | Quaternary salt of cinnamide compound |
AU2007329066B2 (en) * | 2006-12-07 | 2012-04-12 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
WO2008068185A1 (en) | 2006-12-07 | 2008-06-12 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives as via receptor antagonists |
CA2674518A1 (en) * | 2006-12-22 | 2008-07-03 | F.Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
CN101589046B (en) * | 2006-12-29 | 2011-09-21 | 弗·哈夫曼-拉罗切有限公司 | Azaspiro derivatives |
TW200848054A (en) | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
AR068121A1 (en) | 2007-08-31 | 2009-11-04 | Eisai R&D Man Co Ltd | MULTICICLICAL COMPOUNDS TO TREAT NEURODEGENERATIVE DISEASES |
US8470819B2 (en) | 2008-11-03 | 2013-06-25 | Merck Sharp & Dohme Corp. | Benzimidazole and aza-benzimidazole carboxamides |
CN103119028B (en) | 2010-10-01 | 2016-05-25 | 大正制药株式会社 | 1,2,4-triazolone derivative |
TWI630194B (en) | 2013-03-14 | 2018-07-21 | 凱立拉製藥公司 | Bicyclic analgesic compounds |
WO2015089170A1 (en) | 2013-12-12 | 2015-06-18 | Kalyra Pharmaceuticals, Inc. | Bicyclic alkyl compounds and synthesis |
JP6741343B2 (en) | 2014-03-07 | 2020-08-19 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | Propellane derivatives and synthesis |
CA2961605C (en) | 2014-09-17 | 2023-01-10 | Kalyra Pharmaceuticals, Inc. | Bicyclic compounds |
ES2712886T3 (en) | 2014-09-24 | 2019-05-16 | Bayer Pharma AG | Derivatives of pyridobenzazepine and pyridobenzazocine that inhibit factor XIa |
PL3215498T3 (en) * | 2014-11-03 | 2019-02-28 | Bayer Pharma Aktiengesellschaft | Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof |
RU2637101C2 (en) * | 2016-01-11 | 2017-11-29 | Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр вирусологии и микробиологии" (ФГБНУ ФИЦВиМ) | Device for determination of aspired dose of aerosols |
WO2017144624A1 (en) * | 2016-02-23 | 2017-08-31 | Servicio Andaluz De Salud | Piperazine derivatives as antiviral agents with increased therapeutic activity |
WO2017191107A1 (en) | 2016-05-03 | 2017-11-09 | Bayer Pharma Aktiengesellschaft | Amide-substituted phenyltriazole derivatives and uses thereof |
WO2017191114A1 (en) | 2016-05-03 | 2017-11-09 | Bayer Aktiengesellschaft | Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereof |
US9988367B2 (en) | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
EP3452469A1 (en) | 2016-05-03 | 2019-03-13 | Bayer Pharma Aktiengesellschaft | Fluoroalkyl-substituted aryltriazole derivatives and uses thereof |
EP3452457B1 (en) | 2016-05-03 | 2020-03-18 | Bayer Pharma Aktiengesellschaft | Oxoalkyl-substituted phenyltriazole derivatives and uses thereof |
US20190119251A1 (en) | 2016-05-03 | 2019-04-25 | Bayer Pharma Aktiengesellschaft | Amide-substituted aryltriazole derivatives and uses thereof |
EP3456716A4 (en) | 2016-05-09 | 2019-11-06 | Nippon Soda Co., Ltd. | Ring-shaped amine compound and pest control agent |
US10927098B2 (en) | 2016-10-20 | 2021-02-23 | Bayer Pharma Aktiengesellschaft | Hydroxyalkyl-substituted triazole derivatives and uses thereof |
JP7157769B2 (en) | 2017-05-15 | 2022-10-20 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | analgesic compound |
WO2019081302A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Pharma Aktiengesellschaft | Substituted triazole derivatives and uses thereof |
CN111225921A (en) | 2017-10-24 | 2020-06-02 | 拜耳股份公司 | Prodrugs of substituted triazole derivatives and uses thereof |
EP3700899A1 (en) | 2017-10-24 | 2020-09-02 | Bayer Pharma Aktiengesellschaft | Substituted triazole derivatives and uses thereof |
EP3700898A1 (en) | 2017-10-24 | 2020-09-02 | Bayer Pharma Aktiengesellschaft | Substituted triazole derivatives and uses thereof |
WO2019081291A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | Prodrugs of substituted triazole derivatives and uses thereof |
CA3079770A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Pharma Aktiengesellschaft | Amine substituted triazole derivatives and uses thereof |
CA3084308A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | Substituted triazole derivatives and uses thereof |
TW201938171A (en) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | Tricyclic compounds as vasopressin V1a receptor antagonists |
HU231206B1 (en) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4481360A (en) * | 1983-08-26 | 1984-11-06 | The Upjohn Company | 4H-1,2,4-Triazol-3-yl compounds |
AU2000223275A1 (en) * | 2000-02-08 | 2001-08-20 | Yamanouchi Pharmaceutical Co..Ltd. | Novel triazole derivatives |
JP3873746B2 (en) * | 2000-05-19 | 2007-01-24 | アステラス製薬株式会社 | Triazole derivative |
-
2004
- 2004-12-09 CA CA2551038A patent/CA2551038C/en not_active Expired - Fee Related
- 2004-12-09 AU AU2004309164A patent/AU2004309164B2/en not_active Ceased
- 2004-12-09 GE GEAP20049469A patent/GEP20084571B/en unknown
- 2004-12-09 AP AP2006003631A patent/AP2331A/en active
- 2004-12-09 BR BRPI0417267-1A patent/BRPI0417267A/en active Search and Examination
- 2004-12-09 JP JP2006546356A patent/JP4698604B2/en not_active Expired - Fee Related
- 2004-12-09 EA EA200600925A patent/EA010132B1/en not_active IP Right Cessation
- 2004-12-09 OA OA1200600206A patent/OA13347A/en unknown
- 2004-12-09 EP EP04801354A patent/EP1701959A1/en not_active Withdrawn
- 2004-12-09 WO PCT/IB2004/004059 patent/WO2005063754A1/en active Application Filing
- 2004-12-09 KR KR1020067012328A patent/KR100854872B1/en not_active IP Right Cessation
- 2004-12-17 TW TW093139507A patent/TWI287541B/en active
- 2004-12-21 UY UY28693A patent/UY28693A1/en unknown
- 2004-12-21 NL NL1027833A patent/NL1027833C2/en not_active IP Right Cessation
- 2004-12-21 AR ARP040104826A patent/AR047340A1/en not_active Application Discontinuation
- 2004-12-22 PA PA20048620501A patent/PA8620501A1/en unknown
- 2004-12-22 DO DO2004001062A patent/DOP2004001062A/en unknown
-
2005
- 2005-01-03 PE PE2005000032A patent/PE20051051A1/en not_active Application Discontinuation
-
2006
- 2006-05-18 IS IS8472A patent/IS8472A/en unknown
- 2006-06-15 EC EC2006006647A patent/ECSP066647A/en unknown
- 2006-06-15 IL IL176349A patent/IL176349A/en not_active IP Right Cessation
- 2006-06-22 CR CR8481A patent/CR8481A/en not_active Application Discontinuation
- 2006-06-22 MA MA29125A patent/MA28393B1/en unknown
- 2006-07-21 NO NO20063380A patent/NO20063380L/en not_active Application Discontinuation
-
2007
- 2007-03-20 HK HK07102965.0A patent/HK1095822A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NL1027833C2 (en) | 2006-03-06 |
AP2006003631A0 (en) | 2006-06-30 |
AP2331A (en) | 2011-12-05 |
IS8472A (en) | 2006-05-18 |
AU2004309164B2 (en) | 2007-11-15 |
PE20051051A1 (en) | 2005-12-17 |
GEP20084571B (en) | 2008-12-25 |
HK1095822A1 (en) | 2007-07-06 |
AU2004309164A1 (en) | 2005-07-14 |
TWI287541B (en) | 2007-10-01 |
DOP2004001062A (en) | 2005-06-30 |
IL176349A (en) | 2011-11-30 |
JP2007515468A (en) | 2007-06-14 |
TW200528099A (en) | 2005-09-01 |
CR8481A (en) | 2007-12-04 |
EA010132B1 (en) | 2008-06-30 |
EP1701959A1 (en) | 2006-09-20 |
KR20060101546A (en) | 2006-09-25 |
NL1027833A1 (en) | 2005-06-23 |
ECSP066647A (en) | 2006-10-25 |
KR100854872B1 (en) | 2008-08-28 |
AR047340A1 (en) | 2006-01-18 |
CA2551038A1 (en) | 2005-07-14 |
WO2005063754A1 (en) | 2005-07-14 |
JP4698604B2 (en) | 2011-06-08 |
NO20063380L (en) | 2006-09-22 |
MA28393B1 (en) | 2007-01-02 |
IL176349A0 (en) | 2006-10-05 |
BRPI0417267A (en) | 2007-04-17 |
UY28693A1 (en) | 2005-07-29 |
OA13347A (en) | 2007-04-13 |
CA2551038C (en) | 2010-04-27 |
EA200600925A1 (en) | 2006-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8620501A1 (en) | USEFUL COMPOUNDS IN THERAPY | |
CR8497A (en) | DERIVATIVES OF AZEPINOINDOL AS PHARMACEUTICAL AGENTS | |
ECSP088536A (en) | DERIVATIVES OF PIRIDO-, PIRAZO- AND PIRIMIDO-PIRIMIDINA AS MTOR INHIBITORS | |
ECSP055535A (en) | DERIVATIVES OF 1-HETEROCICLIALQUIL-3-SULFONILAZAINDOL OR AZAINDOL AS 5-HYDROXITRIPTAMINE-6 LIGANDS | |
ECSP066882A (en) | IMIDAZOL COMPOUNDS | |
PA8680701A1 (en) | OXINDOL DERIVATIVES | |
PA8740901A1 (en) | ORGANIC COMPOUNDS | |
SV2010003642A (en) | COMPOUNDS | |
CL2008001636A1 (en) | Compounds derived from benzimidazole, angiotensin II receptor antagonists type 1; process of preparing said compounds; intermediary compounds; pharmaceutical composition of the compounds; and its use to treat hypertension, heart failure. | |
UY29099A1 (en) | SUBSTITUTED PHENYLAMINOTIAZOLS AND ITS USE | |
CO6382131A2 (en) | TIENO DERIVATIVES [3,2-C] PIRIDINE AS KINASE INHIBITORS FOR USE IN CANCER TREATMENT | |
CR8837A (en) | USE OF RECEIVER LIGANDS IN THERAPY | |
NI201000036A (en) | DERIVATIVES OF ISOQUINOLINYL AND ISOINDOLINYL AS ANTAGONISTS OF HISTAMINE-3 | |
NI201000035A (en) | DERIVATIVES OF AZACYCLILISOQUINOLINONE AND ISOINDOLINONE AS HISTAMINE-3 ANTAGONISTS | |
CR11098A (en) | PIRIDO COMPOUNDS [2,3-D] PIRIMIDINA-7-ONA AS P13K-ALFA INHIBITORS FOR CANCER TREATMENT | |
UY28255A1 (en) | DOSAGE FORMS AND TREATMENT PROCEDURES USING VEGER INHIBITORS | |
DE602005007765D1 (en) | NEW INDOL OR BENZIMIDAZOLE DERIVATIVES | |
CO6361995A2 (en) | ISOQUINOLINONE DERIVATIVES AS AN NG3 ANTAGONISTS | |
ECSP10010379A (en) | DERIVATIVES OF REPLACED OXINDOL AND ITS USE FOR THE TREATMENT OF VASOPRESINE DEPENDENT DISEASES | |
CO6300937A2 (en) | DERIVATIVES OF 3-CARBOXIPROPIL-AMINOTETRALINA AND RELATED COMPOUNDS AS ANTIGONISTS OF OPIOID RECEPTORS MU | |
TW200700067A (en) | Substituted aryl 1,4-pyrazine derivatives | |
CL2008001112A1 (en) | Uses of compounds derived from pyrido [2,3-d] pyrimidin-4-one to treat itching or a disorder related to itching; combination of the compounds with another drug; and use of the combination to treat itching or a disorder related to itching. | |
PA8571401A1 (en) | IMIDAZOLINILMETIL ARALQUILSULFONAMIDAS | |
BRPI0409505A (en) | compounds as crf1 receptor antagonists | |
ECSP10010625A (en) | IMINOPIRIDINE DERIVATIVES AND USE OF THE SAME |